FABP4 and Hepatic steatosis: However, GSPE treatment remarkably reduced lipid accumulation and CD36 and FABP4 expression in the liver of PFOS-exposed mice, suggesting that GSPE can reverse hepatic steatosis through modulating lipid metabolism.